INBS

Intelligent Bio Solutions In Cross-source read$2.23 3.04%
Health CareCUSIP 36151G709· EOD Sep 4, 2026

Among active 13F managers last quarter, 1 opened and 1 reduced; the largest holder to move was Armistice Capital, LLC (new position). No open-market insider trades in the last 180 days.

Tracked 13F holders
7
1 in Q2 2026 filings
13F value (tracked)
$511K
Smart-money readNeutral
Net sellingNet buying
Funds · active managers, latest 13F
1 adding · 1 trimming
Insiders · Form 4 open-market, 180d
0 buying · 0 selling
US House · STOCK Act, 180d
0 buying · 0 selling

No leg leans either way.

Price & smart-money activity

$2.23 3.04%5Y -100.0%
$1.45$2,178$4,355$6,532$8,70920212022202320242025202619312242
Hover for who · click for detailEnd-of-day closing prices52w $1.55 – $18.80

Who owns INBS?

7 tracked 13F filers · ranked by shares held

7 tracked 13F filers disclose a position in INBS as of the latest SEC 13F filings, a combined $511K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Armistice Capital, LLC130K
$435K
New
+130K sh
Q1 2026
2Geode Capital Management, LLC21K
$48K
−27%
Reduced · −8K sh
Q2 2026
3Vanguard Capital Management LLC6K
$13K
Held
Q2 2026
4Vanguard Fiduciary Trust Co4K
$9K
Held
Q2 2026
5Tower Research Capital LLC (TRC)1K
$4K
−0.8%
Reduced · −10 sh
Q1 2026
6UBS Group AG372
$1K
−91%
Reduced · −4K sh
Q1 2026
7Osaic Holdings, Inc.200
$670
New
+200 sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is INBS being bought or sold by institutions?

Last quarter, 1 fund opened a new position in INBS, while 1 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
1
fund took a first position
Reduced
1
reduced, still holding
Biggest moves · ranked by size of the change, positions above a floor

Funds that own INBS also own

CompanyCo-held byTheir position there
Nvidia CorpNVDA3 funds$1.1B
Amazon.com IncAMZN3 funds$1000.0M
Micron Technology IncMU3 funds$774.3M
Meta Platforms Inc-Class AMETA3 funds$579.1M
Uber Technologies IncUBER3 funds$410.6M
Microsoft CorpMSFT3 funds$341.7M
Analog Devices IncADI3 funds$277.7M
Intuitive Surgical IncISRG3 funds$262.4M
Ulta Beauty IncULTA3 funds$254.0M
Advanced Micro DevicesAMD3 funds$252.1M
USA Rare Earth IncUSAR3 funds$251.4M
McDonald's CorpMCD3 funds$242.7M

Ranked by how many of INBS's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in INBS.

Insider activity (Form 4)

Full insider page →
Net · 180d
$0
0 open-market transactions
DateInsiderRoleActionSharesValue
Oct 4, 2023Sakiris Spiro KevinChief Financial OfficerBuy (P)113K
Oct 4, 2023Towers ChristopherDirectorBuy (P)9K
Sep 1, 2023Simeonidis HarryCEOBuy (P)50$93
Aug 31, 2023Simeonidis HarryCEOBuy (P)100$192
Jun 22, 2022Sakiris Spiro KevinChief Financial OfficerBuy (P)5K$3K
Jun 17, 2022Sakiris Spiro KevinChiefFinancial OfficerBuy (P)16K$10K
Feb 17, 2022Life Science Biosensor Diagnostics Pty LtdInsiderSell (S)576K$294K
Feb 16, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSell (S)100K$63K
Feb 15, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSell (S)100K$68K
Feb 14, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSell (S)100K$70K
Feb 11, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSell (S)100K$75K
Feb 10, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSell (S)100K$84K

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
03
Insiders
Form 4 open-market
00$0
US House
STOCK Act trades
00$0
Sector rotation
INBS is in Health Care, which smart money is rotating OUT OF
$6.6B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

1 tracked filers in Q2 2026 filingsstill filing
059Q4 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $48K
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

15 most recent

Keep exploring

Connected entities for INBS

Browse more

Build

Ask your agent what changed in INBS

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/INBS/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for INBS.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for INBS. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.